{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T02:10:12Z","timestamp":1787278212507,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bpobgyn.2025.102640","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T23:19:51Z","timestamp":1752880791000},"page":"102640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Current and emerging data sources for assessment of ovarian toxicity in children, adolescents and young adults with cancer"],"prefix":"10.1016","volume":"102","author":[{"given":"Harmonie B.","family":"Strohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen T.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6671-5151","authenticated-orcid":false,"given":"H.","family":"Irene Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2025.102640_bib1","unstructured":"Surveillance E, and End Results (SEER) Program. SEER\u2217Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (1973-2014 varying) - Linked To County Attributes - Total U.S., 1969-2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission. www.seer.cancer.gov\/seerstat."},{"key":"10.1016\/j.bpobgyn.2025.102640_bib2","series-title":"American cancer society: cancer treatment & survivorship facts & figures 2016-2017","first-page":"2016","year":"2016"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib3","unstructured":"American Cancer Society. Cancer facts & figuyres 2025. American Cancer Society Accessed July 6, 2025."},{"issue":"9","key":"10.1016\/j.bpobgyn.2025.102640_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(13)70251-1","article-title":"Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort","volume":"14","author":"Barton","year":"2013","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102640_bib5","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11764-014-0354-6","article-title":"Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study","volume":"8","author":"Wasilewski-Masker","year":"2014","journal-title":"J Cancer Surviv"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102640_bib7","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"4","author":"Zhu","year":"2019","journal-title":"Lancet Public Health"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102640_bib8","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/humrep\/deaa124","article-title":"Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies","volume":"35","author":"Zhu","year":"2020","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102640_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00198-003-1408-1","article-title":"Early menopause: increased fracture risk at older age","volume":"14","author":"van Der Voort","year":"2003","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102640_bib10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.051775","article-title":"Premature menopause, clonal hematopoiesis, and coronary artery disease in postmenopausal women","volume":"143","author":"Honigberg","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102640_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13697137.2015.1094784","article-title":"Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis","volume":"19","author":"Tao","year":"2016","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102640_bib12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11764-018-0695-7","article-title":"Childbirth after adolescent and young adult cancer: a population-based study","volume":"12","author":"Nichols","year":"2018","journal-title":"J Cancer Surviv"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102640_bib13","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.26403","article-title":"Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer","volume":"118","author":"Letourneau","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(92)91335-8","article-title":"Early menopause in long-term survivors of cancer during adolescence","volume":"166","author":"Byrne","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"27","key":"10.1016\/j.bpobgyn.2025.102640_bib15","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1200\/JCO.20.00722","article-title":"Chronic comorbidities among survivors of adolescent and young adult cancer","volume":"38","author":"Chao","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102640_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41416-024-02818-0","article-title":"Live birth and maternity outcome in childhood and adolescent cancer survivors under 18 years at diagnosis: a 40-year population-based cohort study","volume":"131","author":"Wallace","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib17","first-page":"1","article-title":"Pregnancy and child health outcomes in pediatric and young adult leukemia and lymphoma survivors: a systematic review","author":"Shliakhtsitsava","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102640_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1603770","article-title":"Best practices in counseling young female cancer survivors on reproductive health","volume":"35","author":"Shliakhtsitsava","year":"2017","journal-title":"Semin Reprod Med"},{"issue":"21","key":"10.1016\/j.bpobgyn.2025.102640_bib19","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review","volume":"36","author":"van Dorp","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102640_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz008","article-title":"Cancer treatment-related infertility: a critical review of the evidence","volume":"3","author":"Poorvu","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2016.11.006","article-title":"Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review","volume":"53","author":"Overbeek","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.bpobgyn.2025.102640_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.6004\/jnccn.2018.7023","article-title":"Management of primary ovarian insufficiency symptoms in survivors of childhood and adolescent cancer","volume":"16","author":"Gargus","year":"2018","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102640_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(19)30818-6","article-title":"Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE)","volume":"21","author":"Clark","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102640_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pbc.24198","article-title":"Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study report","volume":"60","author":"Chow","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.bpobgyn.2025.102640_bib26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(13)70251-1","article-title":"Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort","volume":"14","author":"Barton","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102640_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2016.06.032","article-title":"Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature","volume":"106","author":"Bentivegna","year":"2016","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102640_bib28","first-page":"589","article-title":"Developing a post-treatment survivorship care plan to help breast cancer survivors understand their fertility","volume":"26","author":"Gorman","year":"2018","journal-title":"Support Care Cancer : Off J Multinatl Support Care in Cancer"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102640_bib29","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/humrep\/deu280","article-title":"'Will I be able to have a baby?' Results from online focus group discussions with childhood cancer survivors in Sweden","volume":"29","author":"Nilsson","year":"2014","journal-title":"Hum Reprod"},{"issue":"20","key":"10.1016\/j.bpobgyn.2025.102640_bib30","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1200\/JCO.2004.01.159","article-title":"Web-based survey of fertility issues in young women with breast cancer","volume":"22","author":"Partridge","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102640_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11764-011-0211-9","article-title":"How do you feel about fertility and parenthood? The voices of young female cancer survivors","volume":"6","author":"Gorman","year":"2012","journal-title":"J Cancer Surviv"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102640_bib32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/cncr.29133","article-title":"Experiencing reproductive concerns as a female cancer survivor is associated with depression","volume":"121","author":"Gorman","year":"2015","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102640_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/djr541","article-title":"Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review","volume":"104","author":"Howard-Anderson","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib35","unstructured":"World Population Review. Age of Menopause by country 20242024."},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102640_bib36","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.fertnstert.2016.02.028","article-title":"Impact of female age and nulligravidity on fecundity in an older reproductive age cohort","volume":"105","author":"Steiner","year":"2016","journal-title":"Fertil Steril"},{"issue":"14","key":"10.1016\/j.bpobgyn.2025.102640_bib37","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib38","series-title":"Current evaluation of amenorrhea: a committee opinion","year":"2024"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102640_bib39","doi-asserted-by":"crossref","first-page":"e1002","DOI":"10.1210\/clinem\/dgaa797","article-title":"Beyond premature ovarian insufficiency: staging reproductive aging in adolescent and young adult cancer survivors","volume":"106","author":"Medica","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102640_bib40","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102640_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.fertnstert.2004.06.066","article-title":"Follicular phase hormone levels and menstrual bleeding status in the approach to menopause","volume":"83","author":"Freeman","year":"2005","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102640_bib42","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1210\/jc.2005-1374","article-title":"The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition","volume":"90","author":"Randolph","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102640_bib43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/gme.0b013e318205e2ac","article-title":"Predicting age at menopause from serum antimullerian hormone concentration","volume":"18","author":"Tehrani","year":"2011","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102640_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2012-3176","article-title":"Modeling age at menopause using serum concentration of anti-mullerian hormone","volume":"98","author":"Tehrani","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102640_bib45","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1210\/jc.2012-1422","article-title":"Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN)","volume":"97","author":"Tepper","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102640_bib46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.maturitas.2015.06.026","article-title":"Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: the CARDIA Women's Study","volume":"81","author":"Nair","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib47","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-00724","article-title":"Does AMH relate to timing of menopause? Results of an Individual Patient Data meta- analysis","author":"Depmann","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102640_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib50","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz283","article-title":"Anti-mullerian hormone and impending menopause in late reproductive age: the study of women's health across the nation","author":"Finkelstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib51","article-title":"Anti-mullerian hormone for predicting the final menstrual period the study of women's health across the nation (SWAN)","author":"Santoro","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102640_bib52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12020-016-1068-5","article-title":"How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields","volume":"54","author":"Gleicher","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102640_bib53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.fertnstert.2004.10.040","article-title":"The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict \"low responders\"","volume":"83","author":"Ho","year":"2005","journal-title":"Fertil Steril"},{"issue":"14","key":"10.1016\/j.bpobgyn.2025.102640_bib54","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association between biomarkers of ovarian reserve and infertility among older women of reproductive age","volume":"318","author":"Steiner","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102640_bib55","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2015-2474","article-title":"Is anti-mullerian hormone associated with fecundability? Findings from the EAGeR trial","volume":"100","author":"Zarek","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.fertnstert.2017.11.014","article-title":"Association of testosterone and antimullerian hormone with time to pregnancy and pregnancy loss in fecund women attempting pregnancy","volume":"109","author":"Sjaarda","year":"2018","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102640_bib57","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1210\/jc.2010-0930","article-title":"Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients","volume":"95","author":"Hagen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102640_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12916-016-0699-y","article-title":"Back to the basics of ovarian aging: a population-based study on longitudinal anti-Mullerian hormone decline","volume":"14","author":"de Kat","year":"2016","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib59","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102640_bib60","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2011-3362","article-title":"Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging","volume":"97","author":"Harlow","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102640_bib61","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib64","article-title":"A multicomponent telehealth intervention to improve oncofertility care delivery among young cancer patients: a pilot study","author":"Yang","year":"2022","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib65","unstructured":"UC San Diego Reproductive Health After Cancer Research Group. Oncofertility Risk. Accessed July 6, 2025, https:\/\/oncofertilityrisk.com\/en\/home\/."},{"key":"10.1016\/j.bpobgyn.2025.102640_bib66","unstructured":"(FDA) USFaDA. S5(R3) Detection of Reproductive and Developmental Toxicity for Human Pharmaceuticals. U.S. Food and Drug Administration. Accessed September 25, 2024. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/s5r3-detection-reproductive-and-developmental-toxicity-human-pharmaceuticals."},{"key":"10.1016\/j.bpobgyn.2025.102640_bib67","series-title":"S5(R3) detection of reproductive and developmental toxicity for human pharmaceuticals: guidance for industry","year":"2020"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib68","unstructured":"Administration USFaD. FDA Adverse Event Reporting System (FAERS) Public Dashboard. U.S. Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard."},{"key":"10.1016\/j.bpobgyn.2025.102640_bib69","series-title":"The human protein atlas: a spatial map of the human proteome","first-page":"233","author":"Thul","year":"2018"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.22.1.213","article-title":"Administrative data for public health surveillance and planning","volume":"22","author":"Virnig","year":"2001","journal-title":"Annu Rev Publ Health"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102640_bib72","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/clinem\/dgaa172","article-title":"Modeling variation in the reproductive lifespan of female adolescent and young adult cancer survivors using AMH","volume":"105","author":"Su","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dey229","article-title":"Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve","author":"van den Berg","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib74","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00965","article-title":"Gonadal functioning and perceptions of infertility risk among adult survivors of childhood cancer: a report from the st jude lifetime cohort study","author":"Lehmann","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib75","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.fertnstert.2017.11.016","article-title":"Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome","volume":"109","author":"Shandley","year":"2018","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102640_bib76","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2022.01.016","article-title":"Long-term antimullerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors","volume":"117","author":"Zhou","year":"2022","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102640_bib77","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.fertnstert.2022.08.049","article-title":"Platinum chemotherapy causes reproductive harm in female adolescent and young adult cancer (AYA) survivors","volume":"118","author":"Zhou","year":"2022","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102640_bib78","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.fertnstert.2024.01.039","article-title":"Association of platinum-based chemotherapy with live birth and infertility in female survivors of adolescent and young adult cancer","volume":"121","author":"Zhou","year":"2024","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102640_bib79","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1097\/MLR.0000000000000262","article-title":"Using procedure codes to define radiation toxicity in administrative data: the devil is in the details","volume":"55","author":"Meyer","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib80","doi-asserted-by":"crossref","DOI":"10.2196\/56780","article-title":"Potential roles of large language models in the production of systematic reviews and meta-analyses","volume":"26","author":"Luo","year":"2024","journal-title":"J Med Internet Res"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102640_bib81","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/S1470-2045(23)00390-X","article-title":"Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement","volume":"24","author":"Cui","year":"2023","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102640_bib82","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.rbmo.2016.07.005","article-title":"Important steps towards materializing the dream of developing an artificial ovary","volume":"33","author":"Telfer","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2025.102640_bib83","unstructured":"Health NIo. Ex vivo whole ovary culture system for screening gonadotoxicity during drug development, Project details: 10823136. National Institutes of Health Accessed September 25, 2024. https:\/\/reporter.nih.gov\/search\/sJMhkhT3M06cN7uMOemBJA\/project-details\/10823136."},{"key":"10.1016\/j.bpobgyn.2025.102640_bib84","unstructured":"Group CsO. Children's Oncology Group Long-Term Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers version 6.0 - October 2023. Accessed July 6, 2025, http:\/\/www.survivorshipguidelines.org\/pdf\/2018\/COG_LTFU_Guidelines_v5.pdf."},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102640_bib85","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/jayao.2020.0012","article-title":"Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the Pediatric Initiative Network Risk Stratification System","volume":"9","author":"Meacham","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102640_bib86","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","article-title":"Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE consortium and the international late effects of childhood cancer guideline harmonization group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol"},{"issue":"28","key":"10.1016\/j.bpobgyn.2025.102640_bib87","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2015.64.3288","volume":"34","author":"van Dorp","year":"2016","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102640_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277052","article-title":"A predictive model of the effect of therapeutic radiation on the human ovary","volume":"17","author":"Kelsey","year":"2022","journal-title":"PLoS One"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:24:08Z","timestamp":1777116248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693425000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":85,"alternative-id":["S1521693425000641"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102640","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and emerging data sources for assessment of ovarian toxicity in children, adolescents and young adults with cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102640"}}